Role of vitamin D in preventing of COVID-19 infection, progression and severity

Nurshad Ali, Nurshad Ali

Abstract

The outbreak of COVID-19 has created a global public health crisis. Little is known about the protective factors of this infection. Therefore, preventive health measures that can reduce the risk of infection, progression and severity are desperately needed. This review discussed the possible roles of vitamin D in reducing the risk of COVID-19 and other acute respiratory tract infections and severity. Moreover, this study determined the correlation of vitamin D levels with COVID-19 cases and deaths in 20 European countries as of 20 May 2020. A significant negative correlation (p=0.033) has been observed between mean vitamin D levels and COVID-19 cases per one million population in European countries. However, the correlation of vitamin D with COVID-19 deaths of these countries was not significant. Some retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find the correlation when confounding variables are adjusted. Several studies demonstrated the role of vitamin D in reducing the risk of acute viral respiratory tract infections and pneumonia. These include direct inhibition with viral replication or with anti-inflammatory or immunomodulatory ways. In the meta-analysis, vitamin D supplementation has been shown as safe and effective against acute respiratory tract infections. Thus, people who are at higher risk of vitamin D deficiency during this global pandemic should consider taking vitamin D supplements to maintain the circulating 25(OH)D in the optimal levels (75-125nmol/L). In conclusion, there is not enough evidence on the association between vitamin D levels and COVID-19 severity and mortality. Therefore, randomized control trials and cohort studies are necessary to test this hypothesis.

Keywords: COVID-19; Infections; SARS-CoV-2; Vitamin D; Vitamin D supplementation.

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Correlation between vitamin D levels and the number of COVID-19 cases and deaths/1 M population in 20 European countries. Data source: vitamin D concentration from the reference Lips et al. , and COVID-19 cases and mortality as of 20 May 2020 from worldwide COVID-19 pandemic data portal at https://www.worldometers.info/coronavirus/.

References

    1. Holick M.F. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocrine Metab Disord. 2017;18:153–165.
    1. Dankers W., Colin E.M., van Hamburg J.P., Lubberts E. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2017;7:697.
    1. Infante M., Ricordi C., Sanchez J., Clare-Salzler M.J., Padilla N., Fuenmayor V. Influence of vitamin d on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients. 2019;11:2185.
    1. Bouillon R., Marcocci C., Carmeliet G., Bikle D., White J.H., Dawson-Hughes B. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine Rev. 2019;40:1109–1151.
    1. Greiller C.L., Martineau A.R. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7:4240–4270.
    1. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067–1077.
    1. Wang T.-T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285:2227–2231.
    1. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134:1129–1140.
    1. Cannell J.J., Vieth R., Willett W., Zasloff M., Hathcock J.N., White J.H. Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol. 2008;117:864–870.
    1. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–390.
    1. Zhou Y.-F., Luo B.-A., Qin L.-L. The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies. Medicine. 2019;98
    1. Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988.
    1. Watkins J. British Medical Journal Publishing Group; 2020. Preventing a covid-19 pandemic.
    1. Daneshkhah A., Agrawal V., Eshein A., Subramanian H., Roy H.K., Backman V. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.04.08.20058578.
    1. Darling A.L., Ahmadi K.R., Ward K.A., Harvey N.C., Couto Alves A., Dunn-Waters D.K. Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723) [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.04.29.20084277.
    1. De Smet D., De Smet K., Herroelen P., Gryspeerdt S., Martens G.A. Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.05.01.20079376.
    1. Glicio EJ. Vitamin D level of mild and severe elderly cases of COVID-19: a preliminary report. Available at SSRN: ; 2020.
    1. Hastie C.E., Mackay D.F., Ho F., Celis-Morales C.A., Katikireddi S.V., Niedzwiedz C.L. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabet Metab Syndr: Clin Res Rev. 2020;14:561–565.
    1. Ilie P.C., Stefanescu S., Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020 doi: 10.1007/s40520-020-01570-8.
    1. Lau F.H., Majumder R., Torabi R., Saeg F., Hoffman R., Cirillo J.D. Vitamin D insufficiency is prevalent in severe COVID-19 [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.04.24.20075838.
    1. Li Y, Li Q, Zhang N, Liu Z. Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States (preprint, in review); 2020. doi:10.21203/-32499/v1.
    1. Raharusun P., Priambada S., Budiarti C., Agung E., Budi C. Patterns of COVID-19 mortality and vitamin D: an Indonesian study. SSRN J. 2020 doi: 10.2139/ssrn.3585561.
    1. Teymoori-Rad M., Shokri F., Salimi V., Marashi S.M. The interplay between vitamin D and viral infections. Rev Med Virol. 2019;29:e2032.
    1. Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res. 2020;7:11.
    1. Jakovac H. COVID-19 and vitamin D—is there a link and an opportunity for intervention? Am J Physiol Endocrinol Metab. 2020;318:E589.
    1. Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020
    1. .
    1. Coussens A.K. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochem Photobiol Sci. 2017;16:314–338.
    1. Lang P.O., Aspinall R. Vitamin D status and the host resistance to infections: what it is currently (not) understood. Clin Ther. 2017;39:930–945.
    1. Gruber-Bzura B.M. Vitamin D and influenza—prevention or therapy? Int J Mol Sci. 2018;19:2419.
    1. Gombart A.F., Pierre A., Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12:236.
    1. Rondanelli M., Miccono A., Lamburghini S., Avanzato I., Riva A., Allegrini P. Self-care for common colds: the pivotal role of vitamin D, vitamin C, zinc, and Echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds—practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. Evid-Based Complement Altern Med. 2018;2018
    1. Cantorna M.T., Snyder L., Lin Y.-D., Yang L. Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients. 2015;7:3011–3021.
    1. Alvarez N., Aguilar-Jimenez W., Rugeles M.T. The potential protective role of vitamin D supplementation on HIV-1 infection. Front Immunol. 2019;10:2291.
    1. Tian Y., Rong L. Covid-19 and vitamin D-authors’ reply. Aliment Pharmacol Ther. 2020
    1. Tsujino I., Ushikoshi-Nakayama R., Yamazaki T., Matsumoto N., Saito I. Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia. J Clin Biochem Nutr. 2019;65:245–251.
    1. Zdrenghea M.T., Makrinioti H., Bagacean C., Bush A., Johnston S.L., Stanciu L.A. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27:e1909.
    1. Shi Y., Liu T., Yao L., Xing Y., Zhao X., Fu J. Chronic vitamin D deficiency induces lung fibrosis through activation of the renin–angiotensin system. Sci Rep. 2017;7:1–10.
    1. Skariyachan S., Challapilli S.B., Packirisamy S., Kumargowda S.T., Sridhar V.S. Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections. Front Microbiol. 2019;10
    1. McCartney D.M., Byrne D.G. Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Irish Med J. 2020;113:58.
    1. Vankadari N., Wilce J.A. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microb Infect. 2020;9:601–604.
    1. Komolmit P., Charoensuk K., Thanapirom K., Suksawatamnuay S., Thaimai P., Chirathaworn C. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial. PLoS ONE. 2017;12
    1. Miroliaee A.E., Salamzadeh J., Shokouhi S., Sahraei Z. The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care. 2018;44:300–305.
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020
    1. Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020 jmv.26097.
    1. Surveillances V. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Wkly. 2020;2:113–122.
    1. Poudel-Tandukar K., Poudel K.C., Jimba M., Kobayashi J., Johnson C.A., Palmer P.H. Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection. AIDS Res Hum Retroviruses. 2013;29:528–534.
    1. Dancer R.C., Parekh D., Lax S., D’Souza V., Zheng S., Bassford C.R. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) Thorax. 2015;70:617–624.
    1. Manion M., Hullsiek K.H., Wilson E.M., Rhame F., Kojic E., Gibson D. Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons. PLoS ONE. 2017;12:e0175517.
    1. Lu D., Zhang J., Ma C., Yue Y., Zou Z., Yu C. Link between community-acquired pneumonia and vitamin D levels in older patients. Z Gerontol Geriatr. 2018;51:435–439.
    1. Hou Y.-M., Zhao J.-Y., Liu H.-Y. Impact of serum 25-hydroxyvitamin D on cardiac prognosis in Chinese patients with heart failure. Br J Nutr. 2019;122:162–171.
    1. Pittas A.G., Dawson-Hughes B., Sheehan P., Ware J.H., Knowler W.C., Aroda V.R. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520–530.
    1. Autier P., Mullie P., Macacu A., Dragomir M., Boniol M., Coppens K. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabet Endocrinol. 2017;5:986–1004.
    1. Rejnmark L., Bislev L.S., Cashman K.D., Eiríksdottir G., Gaksch M., Grübler M. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS ONE. 2017;12:e0180512.
    1. Bergman P., Lindh ÅU, Björkhem-Bergman L., Lindh J.D. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2013;8:e65835.
    1. Charan J., Goyal J., Saxena D., Yadav P. Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3:300.
    1. Martineau A.R., Jolliffe D.A., Hooper R.L., Greenberg L., Aloia J.F., Bergman P. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017:i6583.
    1. Lips P., Cashman K.D., Lamberg-Allardt C., Bischoff-Ferrari H.A., Obermayer-Pietsch B., Bianchi M.L. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol. 2019:P23–P54.
    1. Alipio M. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-2019). Available at SSRN 3571484; 2020.
    1. Tan C.W., Ho L.P., Kalimuddin S., Cherng B.P.Z., Teh Y.E., Thien S.Y. A cohort study to evaluate the effect of combination Vitamin D. Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.06.01.20112334.
    1. Guan W., Liang W., Zhao Y., Liang H., Chen Z., Li Y. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547.
    1. Ji W., Huh K., Kang M., Hong J., Bae G.H., Lee R. Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea [preprint] Infect Dis (except HIV/AIDS) 2020 doi: 10.1101/2020.05.08.20095174.
    1. Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Lei G.-S., Zhang C., Cheng B.-H., Lee C.-H. Mechanisms of action of vitamin D as supplemental therapy for pneumocystis pneumonia. Antimicrob Agents Chemother. 2017;61
    1. Mousavi S., Bereswill S., Heimesaat M.M. Immunomodulatory and antimicrobial effects of vitamin C. Eur J Microbiol Immunol (Bp) 2019;9:73–79.
    1. Colunga Biancatelli R.M.L., Berrill M., Marik P.E. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther. 2020;18:99–101.
    1. Vieth R., Kimball S., Hu A., Walfish P.G. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8.
    1. Bischoff-Ferrari H.A., Shao A., Dawson-Hughes B., Hathcock J., Giovannucci E., Willett W.C. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21:1121–1132.
    1. Charoenngam N., Shirvani A., Kalajian T.A., Song A., Holick M.F. The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: a randomized, double-blinded, dose-response study. Anticancer Res. 2020;40:551–556.
    1. Mazahery H., von Hurst P. Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients. 2015;7:5111–5142.
    1. Fabbri A., Infante M., Ricordi C. Editorial-Vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections. Eur Rev Med Pharmacol Sci. 2020;24:4038–4042.
    1. Uwitonze A.M., Razzaque M.S. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc. 2018;118:181–189.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren